Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Medexus Pharmaceuticals Inc (MDP.TO)

Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Medexus and medac Conclude Negotiations to Amend US Treosulfan Agreement, Setting Regulatory Milestone Amounts and Payment Schedule Newsfile - Mon Dec 2, 6:06AM CST

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - December 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company recently entered into a fourth amendment...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada Newsfile - Mon Nov 18, 6:04AM CST

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 18, 2024) - Earlier in November 2024, Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) successfully completed a negotiation process with...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Announces Strong Fiscal Q2 2025 Results Newsfile - Thu Nov 7, 4:44PM CST

Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA* of $6.0 millionManagement to host conference call at 8:00 AM Eastern time on...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Schedules Second Fiscal Quarter 2025 Conference Call Newsfile - Tue Oct 29, 4:04PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 29, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, November...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors Newsfile - Thu Sep 19, 4:34PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 19, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Provides Update on Treosulfan NDA Review Process and Extended PDUFA Goal Date Newsfile - Mon Sep 16, 6:42AM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 16, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has been informed by medac, licensor of Medexus's commercialization rights...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Announces Strong Fiscal Q1 2025 Results Newsfile - Wed Aug 7, 4:44PM CDT

Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA* of $6.1 millionManagement to host conference call at 8:00 AM Eastern time on...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Schedules First Fiscal Quarter 2025 Conference Call Newsfile - Tue Jul 30, 4:38PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, August...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024 Newsfile - Tue Jun 25, 4:38PM CDT

FDA has Accepted for Review the Treosulfan NDAManagement to host conference call at 8:00 AM Eastern time on Wednesday, June 26, 2024Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2024)...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call Newsfile - Tue Jun 18, 4:06PM CDT

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, June 26,...

MEDXF : 2.0700 (+9.18%)
MDP.TO : 3.05 (+8.16%)

Barchart Exclusives

Why This Dividend Stock Just Scored a Rare Upgrade Barchart - Mon Dec 23, 6:30PM CST
Bristol Myers Squibb, a global biopharma company, has received a rare upgrade from Jefferies due to its promising pipeline and strategic partnerships. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot